MA50774A1 - Procédé de production d'un dérivé de diphénylméthane - Google Patents
Procédé de production d'un dérivé de diphénylméthaneInfo
- Publication number
- MA50774A1 MA50774A1 MA50774A MA50774A MA50774A1 MA 50774 A1 MA50774 A1 MA 50774A1 MA 50774 A MA50774 A MA 50774A MA 50774 A MA50774 A MA 50774A MA 50774 A1 MA50774 A1 MA 50774A1
- Authority
- MA
- Morocco
- Prior art keywords
- synthesis
- linear
- diphenylmethane derivative
- production
- route
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D9/00—Crystallisation
- B01D9/005—Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B51/00—Introduction of protecting groups or activating groups, not provided for in the preceding groups
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La présente invention concerne un procédé amélioré de production d'un dérivé de diphénylméthane qui est efficace comme inhibiteur du cotransporteur du glucose dépendant du sodium (sglt), le procédé étant exécuté à l'aide d'un procédé de synthèse convergent dans lequel chaque groupe majeur est séparément synthétisé et ensuite couplé. Ainsi, comparativement à un procédé de synthèse linéaire présenté dans les documents existants, la voie de synthèse est compacte et le rendement peut être accru, et les facteurs de risque inhérents à la voie de synthèse linéaire peuvent être réduits. En outre, la forme cristalline du composé produit selon le procédé offre de superbes caractéristiques physico-chimiques, et ainsi peut être efficacement utilisée dans les domaines tels que la fabrication pharmaceutique.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20160075910 | 2016-06-17 | ||
PCT/KR2017/006271 WO2017217792A1 (fr) | 2016-06-17 | 2017-06-15 | Procédé de production d'un dérivé de diphénylméthane |
Publications (2)
Publication Number | Publication Date |
---|---|
MA50774A1 true MA50774A1 (fr) | 2021-03-31 |
MA50774B1 MA50774B1 (fr) | 2022-02-28 |
Family
ID=60664449
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA44545A MA44545B2 (fr) | 2016-06-17 | 2017-06-15 | Procédé de production d'un dérivé de diphénylméthane |
MA50774A MA50774B1 (fr) | 2016-06-17 | 2017-06-15 | Procédé de production d'un dérivé de diphénylméthane |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA44545A MA44545B2 (fr) | 2016-06-17 | 2017-06-15 | Procédé de production d'un dérivé de diphénylméthane |
Country Status (29)
Country | Link |
---|---|
US (2) | US10640496B2 (fr) |
EP (2) | EP3663292B1 (fr) |
JP (4) | JP6763978B2 (fr) |
KR (2) | KR102233229B1 (fr) |
CN (2) | CN113651803B (fr) |
AU (1) | AU2017285813B2 (fr) |
BR (1) | BR112018076243A2 (fr) |
CA (2) | CA3081033C (fr) |
CL (1) | CL2018003645A1 (fr) |
CO (1) | CO2018014018A2 (fr) |
DK (2) | DK3663292T3 (fr) |
DO (1) | DOP2018000287A (fr) |
EC (1) | ECSP19000185A (fr) |
ES (2) | ES2898336T3 (fr) |
HR (1) | HRP20211670T8 (fr) |
HU (1) | HUE056428T2 (fr) |
MA (2) | MA44545B2 (fr) |
MX (2) | MX2021008988A (fr) |
NZ (1) | NZ749398A (fr) |
PE (2) | PE20240590A1 (fr) |
PH (1) | PH12018550206A1 (fr) |
PL (2) | PL3663292T3 (fr) |
PT (2) | PT3473621T (fr) |
RS (1) | RS62550B1 (fr) |
SA (1) | SA518400666B1 (fr) |
SG (2) | SG11201811154QA (fr) |
SI (1) | SI3663292T1 (fr) |
TN (1) | TN2018000437A1 (fr) |
WO (1) | WO2017217792A1 (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102011054773A1 (de) | 2011-10-25 | 2013-04-25 | Vb Autobatterie Gmbh & Co. Kgaa | Anschlusspol für einen Akkumulator, Akkumulatorgehäuse und Maschine zur Herstellung eines Anschlusspols |
MX2021001732A (es) * | 2018-08-13 | 2021-06-23 | Daewoong Pharmaceutical Co Ltd | Preparacion de intermedio util para la sintesis de inhibidor de sglt. |
CN112341416A (zh) * | 2019-08-09 | 2021-02-09 | 天津津艺医药科技发展有限责任公司 | 一种制备苯并含氧脂杂环衍生物的方法 |
WO2021172955A1 (fr) | 2020-02-27 | 2021-09-02 | 주식회사 대웅제약 | Intermédiaire utile pour la synthèse d'un inhibiteur de sglt et procédé de préparation d'un inhibiteur de sglt l'utilisant |
CN112094253B (zh) * | 2020-09-10 | 2023-01-10 | 株式会社大熊制药 | 用于制备sglt抑制剂中间体的合成方法 |
US20230322699A1 (en) | 2020-09-10 | 2023-10-12 | Daewoong Pharmaceutical Co., Ltd. | Synthesis method for preparing sglt inhibitor intermediate |
CN113200860A (zh) * | 2021-04-29 | 2021-08-03 | 爱斯特(成都)生物制药股份有限公司 | 一种sglt2抑制剂中间体的制备方法 |
CN113801010A (zh) * | 2021-11-18 | 2021-12-17 | 山东诚创蓝海医药科技有限公司 | 一种5-溴-2-氯苯甲酸的制备方法 |
CN113912487B (zh) * | 2021-11-23 | 2024-05-28 | 山东研峰新材料科技有限公司 | 一种2,5-双卤代苯甲酸的合成方法 |
KR20230110001A (ko) * | 2022-01-14 | 2023-07-21 | 주식회사 대웅제약 | Ssglt 저해제의 합성에 유용한 중간체의 제조 방법 |
KR20240044190A (ko) | 2022-09-28 | 2024-04-04 | 주식회사 대웅제약 | 이나보글리플로진의 신규한 결정형 및 이의 제조방법 |
KR20240044194A (ko) | 2022-09-28 | 2024-04-04 | 주식회사 대웅제약 | 이나보글리플로진의 신규한 공결정 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4966907A (en) * | 1988-08-12 | 1990-10-30 | Merck & Co., Inc. | 6-substituted 5-hydroxy-2,3-dihydrobenzofurans as inhibitors of leukotriene biosynthesis |
DK2896397T4 (da) * | 2003-08-01 | 2020-11-16 | Mitsubishi Tanabe Pharma Corp | Nye forbindelser med hæmmende aktivitet mod natriumafhængig glukosetransportør |
EP2183263B1 (fr) | 2007-07-26 | 2011-10-26 | Lexicon Pharmaceuticals, Inc. | Procédés et composés utiles pour la préparation d'inhibiteurs de co-transporteur 2 de sodium-glucose |
AR075262A1 (es) | 2008-07-30 | 2011-03-23 | Ferrer Int | Compuestos de 1,6-dihidro-2h-3-oxa-6-aza-as-indaceno, proceso para prepararlos, composicion farmaceutica que los comprende, sus usos como medicamentos, o en tratamientos o prevenciones de condiciones asociadas con un funcionamiento alterado de los sistemas regulados por la melatonina, sus usos para |
US8163704B2 (en) | 2009-10-20 | 2012-04-24 | Novartis Ag | Glycoside derivatives and uses thereof |
WO2012041898A1 (fr) | 2010-09-29 | 2012-04-05 | Celon Pharma Sp. Z O.O. | Combinaison de l'inhibiteur de sglt2 et d'un composé de sucre pour le traitement du diabète |
US9034921B2 (en) * | 2011-06-01 | 2015-05-19 | Green Cross Corporation | Diphenylmethane derivatives as SGLT2 inhibitors |
US9340521B2 (en) * | 2013-03-18 | 2016-05-17 | Green Cross Corporation | Method for dual inhibition of SGLT1 and SGLT2 using diphenylmethane derivatives |
FR3017868A1 (fr) * | 2014-02-21 | 2015-08-28 | Servier Lab | Derives d'isoquinoleine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2017
- 2017-06-15 BR BR112018076243-1A patent/BR112018076243A2/pt unknown
- 2017-06-15 MA MA44545A patent/MA44545B2/fr unknown
- 2017-06-15 CN CN202110860586.9A patent/CN113651803B/zh active Active
- 2017-06-15 TN TNP/2018/000437A patent/TN2018000437A1/en unknown
- 2017-06-15 WO PCT/KR2017/006271 patent/WO2017217792A1/fr unknown
- 2017-06-15 CN CN201780036968.1A patent/CN109311861B/zh active Active
- 2017-06-15 AU AU2017285813A patent/AU2017285813B2/en active Active
- 2017-06-15 MX MX2021008988A patent/MX2021008988A/es unknown
- 2017-06-15 MX MX2018015647A patent/MX2018015647A/es unknown
- 2017-06-15 DK DK20152959.1T patent/DK3663292T3/da active
- 2017-06-15 MA MA50774A patent/MA50774B1/fr unknown
- 2017-06-15 JP JP2018565754A patent/JP6763978B2/ja active Active
- 2017-06-15 KR KR1020170075799A patent/KR102233229B1/ko active Protection Beyond IP Right Term
- 2017-06-15 RS RS20211297A patent/RS62550B1/sr unknown
- 2017-06-15 ES ES20152959T patent/ES2898336T3/es active Active
- 2017-06-15 DK DK17813615.6T patent/DK3473621T3/da active
- 2017-06-15 SG SG11201811154QA patent/SG11201811154QA/en unknown
- 2017-06-15 NZ NZ749398A patent/NZ749398A/en unknown
- 2017-06-15 HU HUE20152959A patent/HUE056428T2/hu unknown
- 2017-06-15 CA CA3081033A patent/CA3081033C/fr active Active
- 2017-06-15 HR HRP20211670TT patent/HRP20211670T8/hr unknown
- 2017-06-15 SI SI201730944T patent/SI3663292T1/sl unknown
- 2017-06-15 ES ES17813615T patent/ES2891825T3/es active Active
- 2017-06-15 EP EP20152959.1A patent/EP3663292B1/fr active Active
- 2017-06-15 US US16/310,005 patent/US10640496B2/en active Active
- 2017-06-15 PL PL20152959T patent/PL3663292T3/pl unknown
- 2017-06-15 PT PT17813615T patent/PT3473621T/pt unknown
- 2017-06-15 CA CA3026756A patent/CA3026756C/fr active Active
- 2017-06-15 PT PT201529591T patent/PT3663292T/pt unknown
- 2017-06-15 PE PE2023002240A patent/PE20240590A1/es unknown
- 2017-06-15 SG SG10201911782RA patent/SG10201911782RA/en unknown
- 2017-06-15 PE PE2018003162A patent/PE20190467A1/es unknown
- 2017-06-15 PL PL17813615T patent/PL3473621T3/pl unknown
- 2017-06-15 EP EP17813615.6A patent/EP3473621B1/fr active Active
-
2018
- 2018-12-15 SA SA518400666A patent/SA518400666B1/ar unknown
- 2018-12-17 PH PH12018550206A patent/PH12018550206A1/en unknown
- 2018-12-17 CL CL2018003645A patent/CL2018003645A1/es unknown
- 2018-12-17 DO DO2018000287A patent/DOP2018000287A/es unknown
- 2018-12-21 CO CONC2018/0014018A patent/CO2018014018A2/es unknown
-
2019
- 2019-01-04 EC ECSENADI2019185A patent/ECSP19000185A/es unknown
- 2019-08-30 US US16/557,180 patent/US10889574B2/en active Active
-
2020
- 2020-04-06 JP JP2020068458A patent/JP7352509B2/ja active Active
-
2021
- 2021-03-22 KR KR1020210036824A patent/KR102379584B1/ko active IP Right Grant
- 2021-06-21 JP JP2021102648A patent/JP2021152054A/ja active Pending
-
2023
- 2023-07-06 JP JP2023111632A patent/JP2023145481A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA50774A1 (fr) | Procédé de production d'un dérivé de diphénylméthane | |
EA201200117A1 (ru) | Способ получения водной суспензии органического пестицидного соединения | |
MA32510B1 (fr) | Procede pour l'extraction d'acides gras à partir de biomasse algale | |
MA33368B1 (fr) | Préparation de chlorhydrate de nalmefene à partir de naltrexone | |
EP3929187A3 (fr) | Procédé de production de composé de pyrrole | |
CR8975A (es) | Proceso para la produccion de derivados de amina opticamente activos | |
MA48798B1 (fr) | Procédé de production d'ozanimod | |
MA31325B1 (fr) | Nouveaux procedes | |
MA30079B1 (fr) | Procede de synthese de ferri-succinylcaseine | |
MA32530B1 (fr) | Dérivés de spirocétals cristallins et procédé pour la préparation de dérivés de spirocétals | |
FR2895406B1 (fr) | Procede pour la fabrication de 2,3-dimethylbut-1-ene | |
EP1954134A4 (fr) | Procede de synthetisation de derive 2-phenyl-1h-phenantrho[9,10-d]imidazole | |
SE0302029D0 (sv) | Novel process | |
PH12021550297A1 (en) | Preparation of intermediate useful for synthesis of sglt inhibitor | |
MA40798A1 (fr) | Amines modifiées utiles comme inhibiteurs d'incrustations dans une production d'acide phosphorique par voie humide | |
FR3000641B1 (fr) | Nucleon pour la culture de perles et son procede de preparation | |
BRPI0514000A (pt) | método para a produção de derivados de diarilcicloalquila | |
MA35806B1 (fr) | Nouveau procede de synthese du 3-(2-bromo-4,5-dimethoxyphenil) propanenitrile, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable | |
ATE517890T1 (de) | Verfahren zur herstellung von reinem irbesartan | |
BR132019017038E2 (pt) | processo de obtenção de espilantol | |
MA38535A1 (fr) | Procédé de production d'acide 5-aminolévulinique ou d'un sel de celui-ci | |
PL439738A1 (pl) | Sposób wytwarzania 4',5-dihydroksy-7-O-β-D-(4''-O-metyloglukopiranozylo)-izoflawonu | |
PL436250A1 (pl) | 7-Metoksy-8-O-β-D-(4''-O-metyloglukopiranozylo)-flawon i sposób wytwarzania 7-metoksy-8-O-β-D-(4''-O-metyloglukopiranozylo)-flawonu | |
FR3122845B3 (fr) | Fabrication de Produits Auto-Obturants à partir des Matières d’Une Composition d'élastomère Auto-obturante | |
FR2860230B1 (fr) | Nouveau procede de preparation du cis-octahydro-isoindole |